An Act improving maternal and child health related to Hyperemesis Gravidarum
Bill establishes clinical standards and insurance coverage for Hyperemesis Gravidarum to improve diagnosis, treatment access, and maternal health outcomes during pregnancy.
Bill establishes clinical standards and insurance coverage for Hyperemesis Gravidarum to improve diagnosis, treatment access, and maternal health outcomes during pregnancy.
HD 3919 seeks to improve maternal and child health outcomes by addressing Hyperemesis Gravidarum (severe pregnancy-related nausea and vomiting). The bill likely establishes clinical guidelines, insurance coverage requirements, or healthcare provider training related to this condition. It aims to ensure pregnant individuals with this serious condition receive timely diagnosis and appropriate treatment.
Hyperemesis Gravidarum affects approximately 0.3-2% of pregnancies and can lead to severe dehydration, electrolyte imbalances, weight loss, and mental health complications if untreated. Many pregnant individuals face delayed diagnosis, inadequate treatment access, or insufficient provider education about the condition, resulting in preventable hospitalizations and poor outcomes. Addressing this gap could reduce maternal morbidity and improve quality of life during pregnancy.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.